Molecure S.A. Logo

Molecure S.A.

MOC | WAR

Overview

Corporate Details

ISIN(s):
PLONCTH00011
LEI:
2594003L11V38ZCVKZ09
Country:
Poland
Address:
Warszawa Żwirki i Wigury 101, 02-089 Warszawa
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Molecure S.A. is a clinical-stage biotechnology company that discovers and develops first-in-class small molecule drugs for diseases with significant unmet medical needs. The company focuses on therapies for cancer, as well as inflammatory and fibrotic diseases. Molecure leverages its in-house medicinal chemistry and biology capabilities to identify and modulate novel, unexplored protein and mRNA targets. Its key assets include a broad pipeline of drug candidates and a proprietary discovery platform for targeting mRNA with small molecules. Formerly known as OncoArendi, the company pursues development and commercialization through strategic partnerships, including licensing agreements for its programs.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Molecure S.A.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-07-05 13:28
Regulatory News Service
Komunikat KDPW w sprawie rejestracji akcji serii J - Content (PL)
Polish 551 bytes
2025-07-03 21:19
Share Issue/Capital Change
Dopuszczenie i wprowadzenie akcji do obrotu na rynku regulowanym GPW - Content …
Polish 927 bytes
2025-07-02 20:21
Share Issue/Capital Change
Warunkowa rejestracja akcji serii J w Krajowym Depozycie Papierów Wartościowych…
Polish 1.2 KB
2025-06-30 19:26
Board/Management Information
Życiorysy członków organów Molecure SA
Polish 48.5 KB
2025-06-30 19:26
Board/Management Information
Informacja w sprawie powołania członków organów Spółki na nową kadencję - Conte…
Polish 1.5 KB
2025-06-24 21:14
Post-Annual General Meeting Information
Wykaz akcjonariuszy posiadających co najmniej 5% liczby głosów na Zwyczajnym Wa…
Polish 2.0 KB
2025-06-24 20:50
Post-Annual General Meeting Information
Uchwały podjęte przez ZWZ Molecure 24.06.2025
Polish 480.6 KB
2025-06-24 20:50
Post-Annual General Meeting Information
Treść uchwał podjętych przez Zwyczajne Walne Zgromadzenie w dniu 24 czerwca 202…
Polish 1.2 KB
2025-06-05 15:34
Regulatory News Service
Przyjęcie regulaminu oraz podjęcie uchwały w sprawie przeprowadzenia zwolnienia…
Polish 1.6 KB
2025-06-03 22:25
Pre-Annual General Meeting Information
Projekty uchwał po aktualizacji
Polish 457.9 KB
2025-06-03 22:25
Remuneration Information
Wniosek akcjonariusza
Polish 278.9 KB
2025-06-03 22:25
Pre-Annual General Meeting Information
Zmiana do porządku obrad oraz zgłoszenie projektu uchwały w ramach sprawy wprow…
Polish 4.8 KB
2025-05-29 23:21
Board/Management Information
Sprawozdanie Rady Nadzorczej
Polish 243.1 KB
2025-05-29 23:21
Pre-Annual General Meeting Information
Projekty Uchwał na ZWZ Molecure S.A.
Polish 413.3 KB
2025-05-29 23:21
Remuneration Information
Sprawozdanie o wynagrodzeniach
Polish 245.2 KB

Automate Your Workflow. Get a real-time feed of all Molecure S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Molecure S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
Offers contract R&D, develops tech platforms, and invests in life sciences ventures.
Spain IKM
2cureX AB Logo
Tests cancer drugs on patient-derived micro-tumors for personalized oncology treatments.
Sweden 2CUREX
4SC AG Logo
Developing epigenetic small-molecule drugs for cancers with high unmet medical needs.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using an OMV platform for major infectious diseases.
Sweden ABERA
ABIVAX Logo
Developing oral drugs for chronic inflammatory diseases like ulcerative colitis and Crohn's disease.
France ABVX
Abliva Logo
A clinical-stage biotech developing medicines for rare primary mitochondrial diseases.
Sweden ABLI
Achiko AG Logo
A liquidated health tech firm that developed aptamer diagnostics and a COVID-19 passport app.
Switzerland ACHI
Acticor Biotech Logo
Biopharma developing first-in-class drugs for acute stroke and other thrombotic diseases.
France ALACT
Active Biotech Logo
Develops immunotherapies for cancer and inflammatory diseases with significant unmet needs.
Sweden ACTI
Addex Therapeutics Ltd Logo
Develops oral small molecule drugs, allosteric modulators, for neurological disorders.
Switzerland ADXN